Minimally Invasive Ablation Treatment for Locally Advanced Pancreatic Adenocarcinoma
- 30 August 2013
- journal article
- review article
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 37 (3) , 586-591
Abstract
Pancreatic adenocarcinoma is an aggressive tumour with an extremely poor prognosis, which has not changed significantly during the last 30 years. Prolonged survival is achieved only by R0 resection with macroscopic tumour clearance. However, the majority of the cases are considered inoperable at diagnosis due to local spread or presence of metastatic disease. Chemoradiotherapy is not tolerated by all patients and still fails to prolong survival significantly; neoadjuvant treatment also has limited results on pain control or tumour downstaging. In recent years, there has been a growing interest in the use of ablation therapy for the treatment of nonresectable tumours in various organs. Ablation techniques are based on direct application of chemical, thermal, or electrical energy to a tumour, which leads to cellular necrosis. With ablation, tumour cytoreduction, local control, and relief from symptoms are obtained in the majority of the patients. Inoperable cases of pancreatic adenocarcinoma have been treated by various ablation techniques in the last few years with promising results. The purpose of this review is to present the current status of local ablative therapies in the treatment of pancreatic adenocarcinoma and to investigate on the efficiency and the future trends.Keywords
This publication has 42 references indexed in Scilit:
- Radiofrequency ablation of the pancreas with and without intraluminal duodenal cooling in a porcine modelJournal of Surgical Research, 2013
- Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group TrialJournal of Clinical Oncology, 2011
- Ultrasound-Guided High-Intensity Focused Ultrasound (USgHIFU) Ablation in Pancreatic Metastasis from Renal Cell CarcinomaCardioVascular and Interventional Radiology, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Differential Expression of MicroRNAs in CD34+ Cells of 5q- SyndromeJournal of Hematology & Oncology, 2011
- Microwave Tumor Ablation: Mechanism of Action, Clinical Results, and DevicesJournal of Vascular and Interventional Radiology, 2010
- High Intensity Focused Ultrasound Ablation of Pancreatic Neuroendocrine Tumours: Report of Two CasesCardioVascular and Interventional Radiology, 2010
- Mass transfer model for drug delivery in tissue cells with reversible electroporationInternational Journal of Heat and Mass Transfer, 2008
- High-Intensity Focused Ultrasound: Current Potential and Oncologic ApplicationsAmerican Journal of Roentgenology, 2008
- Tissue Ablation with Irreversible ElectroporationAnnals of Biomedical Engineering, 2005